Enphase Vitality, Inc. (NASDAQ:ENPH) This autumn 2024 Earnings Convention Name February 4, 2024 4:30 PM ET
Firm Members
Zach Freedman – IRBadri Kothandaraman – President and CEOMandy Yang – CFORaghu Belur – Chief Merchandise Officer
Convention Name Members
Brian Lee – Goldman SachsPhil Shen – ROTH Capital PartnersJulien Dumoulin-Smith – JefferiesColin Rusch – OppenheimerAndrew Percoco – Morgan StanleyChristine Cho – BarclaysPraneeth Satish – Wells FargoMark Strouse – JPMorganKashy Harrison – Piper SandlerJoseph Osha – GuggenheimMaheep Mandloi – MizuhoDylan Nassano – Wolfe ResearchGordon Johnson – GLJ ResearchAustin Moeller – CanaccordJeffrey Osborne – TD Cowen
Operator
Good afternoon, everybody and welcome to the Enphase Vitality’s Fourth Quarter 2024 Monetary Outcomes Convention Name. All members will probably be in a listen-only mode. [Operator Instructions] After at the moment’s presentation, there will probably be a possibility to ask questions. [Operator Instructions] Please additionally notice, at the moment’s occasion is being recorded.
At the moment, I would like to show the ground over to Zach Freedman. Please go forward.
Zach Freedman
Good afternoon and thanks for becoming a member of us on at the moment’s convention name to debate Enphase Vitality’s fourth quarter 2024 outcomes. On at the moment’s name are Badri Kothandaraman, our President and Chief Govt Officer; Mandy Yang, our Chief Monetary Officer; and Raghu Belur, our Chief Merchandise Officer.
After the market closed at the moment, Enphase issued a press launch asserting the outcomes for its fourth quarter ended December 31, 2024. Throughout this convention name, Enphase administration will make forward-looking statements together with, however not restricted to, statements associated to our anticipated future monetary efficiency, market tendencies, the capabilities of our know-how and merchandise, and the advantages to householders and installers, our operations, together with manufacturing, customer support, and provide and demand, anticipated development in present and new markets, the timing of latest product introductions, and regulatory and tax issues.
